Literature DB >> 23315168

Fetal origins of hematopoietic failure in a murine model of Fanconi anemia.

Ashley N Kamimae-Lanning1, Natalya A Goloviznina, Peter Kurre.   

Abstract

Hematopoietic failure is the predominant clinical manifestation of Fanconi anemia (FA), a rare, recessively inherited disorder. Mutations in 1 of 15 genes that coordinately function in a complex pathway to maintain DNA integrity also predispose patients to constitutional defects in growth and development. The hematologic manifestations have been considered to reflect the progressive loss of stem cells from the postnatal bone marrow microenvironment. Ethical concerns preclude the study of human hematopoiesis in utero. We report significant late gestational lethality and profound quantitative and qualitative deficiencies in the murine Fancc(-/-) fetal liver hematopoietic stem and progenitor cell pool. Fancc(-/-) fetal liver hematopoietic stem and progenitor cells revealed a significant loss of quiescence and decline in serial repopulating capacity, but no substantial difference in apoptosis or levels of reactive oxygen species. Our studies suggest that compromised hematopoiesis in Fancc(-/-) animals is developmentally programmed and does not arise de novo in bone marrow.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23315168      PMCID: PMC3645055          DOI: 10.1182/blood-2012-06-439679

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  24 in total

1.  Not-so-novel phenotypes in the Fanconi anemia group D2 mouse model.

Authors:  Madeleine Carreau
Journal:  Blood       Date:  2004-03-15       Impact factor: 22.113

2.  Bone marrow failure in Fanconi anemia is triggered by an exacerbated p53/p21 DNA damage response that impairs hematopoietic stem and progenitor cells.

Authors:  Raphael Ceccaldi; Kalindi Parmar; Enguerran Mouly; Marc Delord; Jung Min Kim; Marie Regairaz; Marika Pla; Nadia Vasquez; Qing-Shuo Zhang; Corinne Pondarre; Régis Peffault de Latour; Eliane Gluckman; Marina Cavazzana-Calvo; Thierry Leblanc; Jérôme Larghero; Markus Grompe; Gérard Socié; Alan D D'Andrea; Jean Soulier
Journal:  Cell Stem Cell       Date:  2012-06-07       Impact factor: 24.633

3.  The purification and characterization of fetal liver hematopoietic stem cells.

Authors:  S J Morrison; H D Hemmati; A M Wandycz; I L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

4.  Long-term repopulating abilities of enriched fetal liver stem cells measured by competitive repopulation.

Authors:  C T Jordan; C M Astle; J Zawadzki; K Mackarehtschian; I R Lemischka; D E Harrison
Journal:  Exp Hematol       Date:  1995-08       Impact factor: 3.084

5.  Prenatal identification of potential donors for umbilical cord blood transplantation for Fanconi anemia.

Authors:  A D Auerbach; Q Liu; R Ghosh; M S Pollack; G W Douglas; H E Broxmeyer
Journal:  Transfusion       Date:  1990-10       Impact factor: 3.157

6.  Hematopoietic compartment of Fanconi anemia group C null mice contains fewer lineage-negative CD34+ primitive hematopoietic cells and shows reduced reconstruction ability.

Authors:  M Carreau; O I Gan; L Liu; M Doedens; J E Dick; M Buchwald
Journal:  Exp Hematol       Date:  1999-11       Impact factor: 3.084

7.  Germ cell defects and hematopoietic hypersensitivity to gamma-interferon in mice with a targeted disruption of the Fanconi anemia C gene.

Authors:  M A Whitney; G Royle; M J Low; M A Kelly; M K Axthelm; C Reifsteck; S Olson; R E Braun; M C Heinrich; R K Rathbun; G C Bagby; M Grompe
Journal:  Blood       Date:  1996-07-01       Impact factor: 22.113

8.  Epithelial cancer in Fanconi anemia complementation group D2 (Fancd2) knockout mice.

Authors:  Scott Houghtaling; Cynthia Timmers; Meenakshi Noll; Milton J Finegold; Stephen N Jones; M Stephen Meyn; Markus Grompe
Journal:  Genes Dev       Date:  2003-07-31       Impact factor: 11.361

Review 9.  Fanconi anaemia and leukaemia - clinical and molecular aspects.

Authors:  Marc Tischkowitz; Inderjeet Dokal
Journal:  Br J Haematol       Date:  2004-07       Impact factor: 6.998

10.  Inactivation of Fac in mice produces inducible chromosomal instability and reduced fertility reminiscent of Fanconi anaemia.

Authors:  M Chen; D J Tomkins; W Auerbach; C McKerlie; H Youssoufian; L Liu; O Gan; M Carreau; A Auerbach; T Groves; C J Guidos; M H Freedman; J Cross; D H Percy; J E Dick; A L Joyner; M Buchwald
Journal:  Nat Genet       Date:  1996-04       Impact factor: 38.330

View more
  17 in total

1.  The Fanconi anemia pathway is required for efficient repair of stress-induced DNA damage in haematopoietic stem cells.

Authors:  Paul Kaschutnig; Ruzhica Bogeska; Dagmar Walter; Amelie Lier; Sina Huntscha; Michael D Milsom
Journal:  Cell Cycle       Date:  2015-07-15       Impact factor: 4.534

2.  Pregnancy outcomes in mothers of offspring with inherited bone marrow failure syndromes.

Authors:  Neelam Giri; Helen D Reed; Pamela Stratton; Sharon A Savage; Blanche P Alter
Journal:  Pediatr Blood Cancer       Date:  2017-08-12       Impact factor: 3.167

Review 3.  Stress and DNA repair biology of the Fanconi anemia pathway.

Authors:  Simonne Longerich; Jian Li; Yong Xiong; Patrick Sung; Gary M Kupfer
Journal:  Blood       Date:  2014-09-18       Impact factor: 22.113

Review 4.  DNA repair fidelity in stem cell maintenance, health, and disease.

Authors:  Chinnadurai Mani; P Hemachandra Reddy; Komaraiah Palle
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-04-04       Impact factor: 5.187

5.  Impairment of fetal hematopoietic stem cell function in the absence of Fancd2.

Authors:  Sakiko Suzuki; Ronny R Racine; Nathan A Manalo; Sharon B Cantor; Glen D Raffel
Journal:  Exp Hematol       Date:  2016-12-01       Impact factor: 3.084

6.  Metformin improves defective hematopoiesis and delays tumor formation in Fanconi anemia mice.

Authors:  Qing-Shuo Zhang; Weiliang Tang; Matthew Deater; Ngoc Phan; Andrea N Marcogliese; Hui Li; Muhsen Al-Dhalimy; Angela Major; Susan Olson; Raymond J Monnat; Markus Grompe
Journal:  Blood       Date:  2016-10-18       Impact factor: 22.113

7.  Pluripotent cell models of fanconi anemia identify the early pathological defect in human hemoangiogenic progenitors.

Authors:  Naoya M Suzuki; Akira Niwa; Miharu Yabe; Asuka Hira; Chihiro Okada; Naoki Amano; Akira Watanabe; Ken-Ichiro Watanabe; Toshio Heike; Minoru Takata; Tatsutoshi Nakahata; Megumu K Saito
Journal:  Stem Cells Transl Med       Date:  2015-03-11       Impact factor: 6.940

8.  Metformin: treating the cause of Fanconi anemia?

Authors:  Gerry P Crossan
Journal:  Blood       Date:  2016-12-15       Impact factor: 22.113

9.  Fanconi anemia signaling and Mus81 cooperate to safeguard development and crosslink repair.

Authors:  Meghan Larin; David Gallo; Laura Tamblyn; Jay Yang; Hudson Liao; Nestor Sabat; Grant W Brown; J Peter McPherson
Journal:  Nucleic Acids Res       Date:  2014-07-23       Impact factor: 16.971

10.  Loss of the homologous recombination gene rad51 leads to Fanconi anemia-like symptoms in zebrafish.

Authors:  Jan Gregor Botthof; Ewa Bielczyk-Maczyńska; Lauren Ferreira; Ana Cvejic
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.